Houston, Texas — According to state and local economic development sources Marker Therapeutics plans to invest $887,084.00 to build out 23,351 square feet of new space in Houston. The company plans to occupy the new space at 3200 SW Freeway, Floor 25 in Houston, on or about October 1, 2020. According to the company website At Marker Therapeutics, Inc. we are a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker’s cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e. tumor targets) and kill tumor cells expressing those targets. Once infused into patients, this population of T cells attacks multiple tumor targets and acts to activate the patient’s immune system to produce broad spectrum anti-tumor activity.

To learn more about Marker Therapeutics, visit http://www.markertherapeutics.com/

Company Contact:
Peter Hoang, Chief Executive Officer
phoang@markertherapeutics.com
https://www.linkedin.com/in/peterlhoang/
713-400-6400

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved